Platelet and neutrophil to lymphocyte ratios predict survival in patients with resectable colorectal liver metastases.

导出原文传递

翻译打印收藏纠错

第一作者： Derek J,Erstad

第一单位： Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

作者： Derek J,Erstad ^[1] ; Martin S,Taylor ^[2] ; Motaz,Qadan ^[1] ; Andrea L,Axtell ^[3] ; Bryan C,Fuchs ^[1] ; David L,Berger ^[1] ; Thomas E,Clancy ^[4] ; Kenneth K,Tanabe ^[1] ; David C,Chang ^[3] ; Cristina R,Ferrone ^[5]

作者单位： Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. ^[1] Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. ^[2] Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States; Codman Center for Clinical Effectiveness in Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. ^[3] Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. ^[4] Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. Electronic address: cferrone@mgh.harvard.edu. ^[5]

关键词 Colorectal Hepatectomy Liver metastasis Neutrophil-to-lymphocyte ratio Overall survival Platelet-to-lymphocyte ratio Prognosis